Abstract 1660: Preliminary Safety Tolerability & Efficacy Results of KN046 (an Anti-Pd-l1/ctla-4 Bispecific Antibody) in Combination with Nab-paclitaxel in Patients with Metastatic Triple-Negative Breast Cancer (Mtnbc)
Cancer research（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要